Counterfeit versions of the “next Ozempic” retatrutide are being peddled by the Chinese site GorillaHealing.com, even though the real version will not be approved until at least 2026.
Counterfeit versions of Eli Lilly’s retatrutide, hailed as a potential “new Ozempic,” are being sold directly to U.S. consumers through Chinese websites, although regulatory approval remains years away. Hundreds of marketers are offering the new drug to buyers in the United States through websites such as Made-in-China.com and GorillaHealing.com, the Wall Street Journal reports. Some …